dr guenther klow Guenter, First Edition – AbeBooks Books by Dr. Guenter Klow

Either the GHK-CU isn't suitable for your biochemistry, your protocol needs adjustment, or an external factor is interfering

The Lilly company would be delighted to work with Toronto, Clowes wrote, and hinted, perhaps intentionally, perhaps not, that Toronto could be bypassed: "I have thus far refrained from starting work in our laboratories on the field of this question as I was anxious to avoid in any way intruding on the field of yourself and your associates until you had published your results

G., & Domingues, M

This is especially interesting for GBM patients, since galectin-1 has been identified as a poor prognostic factor, fulfilling a key role in the aggressiveness and immune escape of GBM cells [68, 72, 102,103,104]

The synergy becomes evident when you layer these mechanisms